tetano
Editor, Senior Moderator
J Adolesc Health
. 2020 Oct 14;S1054-139X(20)30522-X.
doi: 10.1016/j.jadohealth.2020.09.001. Online ahead of print.
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population
Kimberly Tilley[SUP] 1 [/SUP], Vladimir Ayvazyan[SUP] 2 [/SUP], Lauren Martinez[SUP] 2 [/SUP], Neha Nanda[SUP] 3 [/SUP], Eric S Kawaguchi[SUP] 4 [/SUP], Maurice O'Gorman[SUP] 5 [/SUP], David Conti[SUP] 4 [/SUP], W James Gauderman[SUP] 4 [/SUP], Sarah Van Orman[SUP] 2 [/SUP]
Affiliations
Abstract
Purpose: The aim of the study was to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in a university student population.
Methods: This was a cross-sectional survey study based on the World Health Organization population-based seroepidemiological investigational protocol for SARS-CoV-2 conducted between April 29, 2020, and May 8, 2020, examining SARS-CoV-2 antibody prevalence among 790 university students in Los Angeles, CA. Participants completed a questionnaire on potential risk factors before blood sampling. Samples were analyzed using the EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG) for the qualitative detection of IgG class antibodies to SARS-CoV-2 in human serum or plasma.
Results: The estimated prevalence of SARS-CoV-2 antibody was 4.0% (3.0%, 5.1%). Factors associated with having a positive test included history of anosmia and/or loss of taste (95% CI: 1.4-9.6). A history of respiratory symptoms, with or without fever, was not associated with a positive antibody test.
Conclusions: Prevalence of SARS-CoV-2 antibodies in the undergraduate and graduate student university population was similar to community prevalence.
Keywords: SARS-CoV-2; Seroprevalence; University.
. 2020 Oct 14;S1054-139X(20)30522-X.
doi: 10.1016/j.jadohealth.2020.09.001. Online ahead of print.
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population
Kimberly Tilley[SUP] 1 [/SUP], Vladimir Ayvazyan[SUP] 2 [/SUP], Lauren Martinez[SUP] 2 [/SUP], Neha Nanda[SUP] 3 [/SUP], Eric S Kawaguchi[SUP] 4 [/SUP], Maurice O'Gorman[SUP] 5 [/SUP], David Conti[SUP] 4 [/SUP], W James Gauderman[SUP] 4 [/SUP], Sarah Van Orman[SUP] 2 [/SUP]
Affiliations
- PMID: 33071164
- PMCID: PMC7557277
- DOI: 10.1016/j.jadohealth.2020.09.001
Abstract
Purpose: The aim of the study was to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in a university student population.
Methods: This was a cross-sectional survey study based on the World Health Organization population-based seroepidemiological investigational protocol for SARS-CoV-2 conducted between April 29, 2020, and May 8, 2020, examining SARS-CoV-2 antibody prevalence among 790 university students in Los Angeles, CA. Participants completed a questionnaire on potential risk factors before blood sampling. Samples were analyzed using the EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG) for the qualitative detection of IgG class antibodies to SARS-CoV-2 in human serum or plasma.
Results: The estimated prevalence of SARS-CoV-2 antibody was 4.0% (3.0%, 5.1%). Factors associated with having a positive test included history of anosmia and/or loss of taste (95% CI: 1.4-9.6). A history of respiratory symptoms, with or without fever, was not associated with a positive antibody test.
Conclusions: Prevalence of SARS-CoV-2 antibodies in the undergraduate and graduate student university population was similar to community prevalence.
Keywords: SARS-CoV-2; Seroprevalence; University.